The cure rate of hemolytic disease is generally related to the type of the disease, with a cure rate of up to 100% for mild forms and more difficult for severe forms. Hemolytic diseases are common in the fetal and neonatal periods and are immune-reactive hemolytic diseases, including ABO hemolytic disease and Rh hemolytic disease, which are caused by the incompatibility of the mother’s and baby’s blood groups. Its cure rate is related to the type of hemolysis. 1. Mild type: mostly ABO hemolysis, usually in the range of physiological jaundice, without obvious anemia, the cure rate of patients can reach 100%. Treatment includes light therapy, etc. 2. Medium type: most patients develop jaundice within 24 hours, which rises rapidly, usually with moderate to severe anemia, and the development of bilirubin encephalopathy can be prevented by aggressive treatment such as albumin transfusion and plasma exchange. If bilirubin encephalopathy develops, it is difficult to cure. 3. Severe: also known as hydrops fetalis type, mostly Rh hemolysis. The fetus will die shortly after birth and is more difficult to cure. Therefore, mothers who are highly suspected of hemolysis should be intervened prenatally and treated actively after birth to prevent complications before cure is possible. Specific diagnosis and treatment should be under the supervision of a physician.